Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease

International Immunology

Volumn 27, Issue 6, 2015, Pages 289-296

  Zidi, Inès ^a   Yahia, Hamza Ben ^a   Bortolotti, Daria ^b   Mouelhi, Leila ^a,c   Laaribi, Ahmed Baligh ^a,d   Ayadi, Shema ^c   Zidi, Nour ^e   Houissa, Fatma ^c   Debbech, Radhouane ^c   Boudabous, Abdellatif ^a   Najjar, Taoufik ^c   Di Luca, Dario ^b   Rizzo, Roberta ^b  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b UNIVERSITY OF FERRARA   (Italy)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

^d FARHAT HACHED HOSPITAL   (Tunisia)

^e UNIVERSITY OF SOUSSE   (Tunisia)

Author keywords

14 bp; conformation; Crohn's disease; HLA G; Polymorphism

Indexed keywords

DIMER; HLA G ANTIGEN; SOLUBLE HLA G ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDEL MUTATION; MALE; PRIORITY JOURNAL; WESTERN BLOTTING; CHEMISTRY; DIMERIZATION; DISEASE COURSE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ONSET AGE; RISK; YOUNG ADULT;

ADULT; AGE OF ONSET; CROHN DISEASE; DIMERIZATION; DISEASE PROGRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-G ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; RISK; SEQUENCE DELETION; YOUNG ADULT;

EID: 84939527468     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxv002     Document Type: Article

References (34)

1. Mudter, J. and Neurath, M. F. 2012. Insight into Crohn's disease pathomorphology. Abdom. Imaging 37:921.
2. Thoreson, R. and Cullen, J. J. 2007. Pathophysiology of inflammatory bowel disease: an overview. Surg. Clin. North Am. 87:575.
3. Raza, A., Yousaf, W., Giannella, R. and Shata, M. T. 2012. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease. Expert Rev. Clin. Immunol. 8:161.
4. González, A., Rebmann, V., LeMaoult, J., Horn, P. A., Carosella, E. D. and Alegre, E. 2012. The immunosuppressive molecule HLA-G and its clinical implications. Crit. Rev. Clin. Lab. Sci. 49:63.
5. Gonen-Gross, T., Achdout, H., Gazit, R. et al. 2003. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 171:1343.
6. Shiroishi, M., Kuroki, K., Ose, T. et al. 2006. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J. Biol. Chem. 281:10439.
7. Marchal-Bras-Goncalves, R., Rouas-Freiss, N., Connan, F. et al. 2001. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant. Proc. 33:2355.
8. Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J. and Carosella, E. D. 2001. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigenspecific CTL cytolysis. J. Immunol. 166:5018.
9. Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J. and Carosella, E. D. 1997. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl Acad. Sci. U.S.A. 94:5249.
10. Le Rond, S., Le Maoult, J., Créput, C. et al. 2004. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur. J. Immunol. 34:649.
11. Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A. and Carosella, E. D. 2001. Soluble HLA-G protein secreted by allospecific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc. Natl Acad. Sci. U.S.A. 98:12150.
12. Amiot, L., Ferrone, S., Grosse-Wilde, H. and Seliger, B. 2011. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell. Mol. Life Sci. 68:417.
13. Carosella, E. D., Gregori, S. and LeMaoult, J. 2011. The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood 118:6499.
14. Le Gal, F. A., Riteau, B., Sedlik, C. et al. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11:1351.
15. Rousseau, P., Le Discorde, M., Mouillot, G., Marcou, C., Carosella, E. D. and Moreau, P. 2003. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum. Immunol. 64:1005.
16. Chen, X. Y., Yan, W. H., Lin, A., Xu, H. H., Zhang, J. G. and Wang, X. X. 2008. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 72:335.
17. Rizzo, R., Bortolotti, D., Fredj, N. B. et al. 2012. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum. Immunol. 73:1140.
18. Rizzo, R., Hviid, T. V., Stignani, M. et al. 2005. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 57:172.
19. Rizzo, R., Melchiorri, L., Simone, L. et al. 2008. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool? Inflamm. Bowel Dis. 14:100.
20. Satsangi, J., Silverberg, M. S., Vermeire, S. and Colombel, J. F. 2006. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749.
21. Consiglio, C. R., Veit, T. D., Monticielo, O. A. et al. 2011. Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens 77:540.
22. Park, G. M., Lee, S., Park, B. et al. 2004. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem. Biophys. Res. Commun. 313:606.
23. Rebmann, V., Lemaoult, J., Rouas-Freiss, N., Carosella, E. D. and Grosse-Wilde, H. 2005. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum. Immunol. 66:853.
24. Tan, Z., Randall, G., Fan, J. et al. 2007. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am. J. Hum. Genet. 81:829.
25. Torres, M. I., Le Discorde, M., Lorite, P. et al. 2004. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int. Immunol. 16:579.
26. Glas, J., Török, H. P., Tonenchi, L. et al. 2007. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Int. Immunol. 19:621.
27. Feger, U., Tolosa, E., Huang, Y. H. et al. 2007. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110:568.
28. Huang, Y. H., Zozulya, A. L., Weidenfeller, C. et al. 2009. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Ann. Neurol. 66:171.
29. Le Friec, G., Gros, F., Sebti, Y. et al. 2004. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules. J. Leukoc. Biol. 76:1125.
30. Efsen, E., Saermark, T., Hansen, A., Bruun, E. and Brynskov, J. 2011. Ramiprilate inhibits functional matrix metalloproteinase activity in Crohn's disease fistulas. Basic Clin. Pharmacol. Toxicol. 109:208.
31. Kossakowska, A. E., Medlicott, S. A., Edwards, D. R. et al. 1999. Elevated plasma gelatinase A (MMP-2) activity is associated with quiescent Crohn's Disease. Ann. N. Y. Acad. Sci. 878:578.
32. Meijer, M. J., Mieremet-Ooms, M. A., van der Zon, A. M. et al. 2007. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. Dig. Liver Dis. 39:733.
33. Rizzo, R., Trentini, A., Bortolotti, D. et al. 2013. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. Mol. Cell. Biochem. 381:243.
34. Gonzalez, A., Alegre, E., Arroyo, A., LeMaoult, J. and Echeveste, J. I. 2011. Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates. Clin. Chem. 57:1013.